148 related articles for article (PubMed ID: 2159272)
1. Expression of intermediate filaments in neuroendocrine tumors.
Kimura N; Nakazato Y; Nagura H; Sasano N
Arch Pathol Lab Med; 1990 May; 114(5):506-10. PubMed ID: 2159272
[TBL] [Abstract][Full Text] [Related]
2. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.
Miettinen M
Arch Pathol Lab Med; 1987 Sep; 111(9):813-8. PubMed ID: 2820344
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical demonstration of intermediate filament cytoskeleton proteins in human endocrine tissues and (neuro-) endocrine tumours.
Hoefler H; Denk H; Lackinger E; Helleis G; Polak JM; Heitz PU
Virchows Arch A Pathol Anat Histopathol; 1986; 409(5):609-26. PubMed ID: 3092460
[TBL] [Abstract][Full Text] [Related]
4. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors.
Komminoth P; Roth J; Schröder S; Saremaslani P; Heitz PU
Lab Invest; 1995 Apr; 72(4):424-31. PubMed ID: 7723281
[TBL] [Abstract][Full Text] [Related]
5. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
[TBL] [Abstract][Full Text] [Related]
6. Varying expression of cytokeratin and neurofilaments in neuroendocrine tumors of human gastrointestinal tract.
Miettinen M; Lehto VP; Dahl D; Virtanen I
Lab Invest; 1985 Apr; 52(4):429-36. PubMed ID: 2580121
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of coexpression of intermediate filaments in fine needle aspirates of human tumors.
Domagala W; Weber K; Osborn M
Acta Cytol; 1988; 32(1):49-59. PubMed ID: 2447723
[TBL] [Abstract][Full Text] [Related]
8. Immunofluorescence microscopic evaluation of the intermediate filament expression of the adrenal cortex and medulla and their tumors.
Miettinen M; Lehto VP; Virtanen I
Am J Pathol; 1985 Mar; 118(3):360-6. PubMed ID: 3883796
[TBL] [Abstract][Full Text] [Related]
9. Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry.
Gould VE; Wiedenmann B; Lee I; Schwechheimer K; Dockhorn-Dworniczak B; Radosevich JA; Moll R; Franke WW
Am J Pathol; 1987 Feb; 126(2):243-57. PubMed ID: 3103452
[TBL] [Abstract][Full Text] [Related]
10. Expression of intermediate filament proteins in thyroid gland and thyroid tumors.
Miettinen M; Franssila K; Lehto VP; Paasivuo R; Virtanen I
Lab Invest; 1984 Mar; 50(3):262-70. PubMed ID: 6199582
[TBL] [Abstract][Full Text] [Related]
11. Detection of epithelial- and neural type of intermediate filament proteins in human lung tumors.
Ramaekers F; Broers J; Rot MK; Oostendorp T; Wagenaar S; Vooijs P
Acta Histochem Suppl; 1987; 34():45-56. PubMed ID: 3033739
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of intermediate filaments in squamous cell carcinomas of upper aerodigestive tract before and after radiation and chemotherapy.
Fischer HP; Wallner F; Maier H; Weber K; Osborn M; Altmannsberger M
Lab Invest; 1989 Oct; 61(4):433-9. PubMed ID: 2477642
[TBL] [Abstract][Full Text] [Related]
13. Familial risk for neuroendocrine tumors.
Anderson RJ; Lynch HT
Curr Opin Oncol; 1993 Jan; 5(1):75-84. PubMed ID: 8094015
[TBL] [Abstract][Full Text] [Related]
14. Primitive neuroectodermal tumors of the central nervous system. Patterns of expression of neuroendocrine markers, and all classes of intermediate filament proteins.
Gould VE; Jansson DS; Molenaar WM; Rorke LB; Trojanowski JQ; Lee VM; Packer RJ; Franke WW
Lab Invest; 1990 Apr; 62(4):498-509. PubMed ID: 2159086
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of neurofilament proteins in neuroendocrine neoplasms.
Shah IA; Schlageter MO; Netto D
Mod Pathol; 1991 Mar; 4(2):215-9. PubMed ID: 1646456
[TBL] [Abstract][Full Text] [Related]
16. [Sipple's syndrome: type II endocrine polyneoplasia (author's transl)].
Bricaire H; Mahoudeau J
Ann Med Interne (Paris); 1979 Dec; 130(12):611-5. PubMed ID: 44158
[TBL] [Abstract][Full Text] [Related]
17. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors.
Agoff SN; Lamps LW; Philip AT; Amin MB; Schmidt RA; True LD; Folpe AL
Mod Pathol; 2000 Mar; 13(3):238-42. PubMed ID: 10757334
[TBL] [Abstract][Full Text] [Related]
18. [Pathology of endocrine polyneoplasms (polyadenomatoses) (author's transl)].
Louvel A; Abelanet R
Ann Med Interne (Paris); 1979 Dec; 130(12):583-9. PubMed ID: 44154
[TBL] [Abstract][Full Text] [Related]
19. Galanin immunoreactivity in neuroendocrine tumors.
Sano T; Vrontakis ME; Kovacs K; Asa SL; Friesen HG
Arch Pathol Lab Med; 1991 Sep; 115(9):926-9. PubMed ID: 1718239
[TBL] [Abstract][Full Text] [Related]
20. Absence of TP53 alterations in pheochromocytomas and medullary thyroid carcinomas.
Herfarth KK; Wick MR; Marshall HN; Gartner E; Lum S; Moley JF
Genes Chromosomes Cancer; 1997 Sep; 20(1):24-9. PubMed ID: 9290950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
